The Mechanistic Review of the Molecular Interface of RNA-Loaded Extracellular Vesicles: Redefining Targeted Therapy for Autoimmune Disorders
Open Access
- 12 May 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4323
Abstract
Traditional treatments of autoimmune diseases relying on systemic immunosuppression often lack curative potential and have severe side effects. Mesenchymal stem cells (MSCs) are a promising alternative due to their immunomodulatory properties; however, whole-cell therapies have certain limitations. MSC-derived extracellular vesicles (EVs), including small vesicles—exosomes—have emerged as a safe cell-free therapeutic platform capable of crossing biological barriers and delivering bioactive cargo with low immunogenicity. Various types of RNAs abundantly produced by host MSCs represent a key element of EV content. In particular, EVs carry small RNAs, which essentially determine cellular life and fate. Our review provides a comprehensive mechanistic framework for the use of RNA-loaded EVs, specifically those carrying microRNAs (miRNAs), small interfering RNAs (siRNAs), and messenger RNAs (mRNAs), in restoring immune homeostasis. We detail the biogenesis and molecular mechanisms governing sorting of RNA into EVs, along with endogenous and exogenous engineering strategies to enhance therapeutic potency. We examine how RNA-loaded EVs modulate immunological processes like reprogramming of macrophage M1-M2 polarization, Th17/Treg balance, and suppression of inflammatory signaling pathways such as NF-κB and the NLRP3 inflammasome. We address critical translational challenges—EV heterogeneity, manufacturing scalability, and need for standardized quality control—while outlining future opportunities for RNA-loaded EV-based therapeutics.Keywords
This publication has 379 references indexed in Scilit:
- Engineered Foxp1 high Exosomes Ameliorates Systemic Lupus ErythematosusAdvanced Science, 2025
- Spleen‐Targeted mRNA Nanoparticles for Modulating B Cell Hyperactivation in Rheumatoid Arthritis TherapyAdvanced Functional Materials, 2024
- 3D‐hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells‐Mediated Immunosuppression and Suppressing Oxidative Stress‐Induced Melanocyte DamageAdvanced Science, 2024
- Oral Administration Properties Evaluation of Three Milk‐Derived Extracellular Vesicles Based on Ultracentrifugation Extraction MethodsAdvanced Healthcare Materials, 2024
- siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary reviewCell Biology International, 2022
- Single‐cell RNA sequencing technologies and applications: A brief overviewClinical and Translational Medicine, 2022
- Global exosome transcriptome profiling reveals biomarkers for multiple sclerosisAnnals of Neurology, 2017
- Long non‐coding RNAs with low expression levels in cells are enriched in secreted exosomesCell Biology International, 2014
- CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+ T cells contributes to their regulatory functionEuropean Journal of Immunology, 2013
- Notch1 modulates mesenchymal stem cells mediated regulatory T‐cell inductionEuropean Journal of Immunology, 2012